review on glp-1 agonists and psychiatric effects An analysis the role of glucagon-like peptide-1 receptor in cognitive mental health disorders Mapping the effectiveness and risks
Description
Various CVOT trials, such as the SELECT, SUSTAIN, and SOUL trials, have demonstrated varying effects on heart diseases over the years [13,39,46]
This information determines whether GLP-1s are appropriate for you
The neuroprotective properties of GLP1R agonists correlate with their ability to cross the bloodbrain barrier
25,26 Effects on Epicardial Adipose Tissue GLP1-RAs decrease the volume of epicardial adipose tissue, which is often elevated in HFpEF and is a source of proinflammatory cytokines and adipokines
Gastroparesis from concepts to management
Exp Clin Endocrinol Diabetes 114 , 417423, (2006)
